Home/Pipeline/Nasal Spray for OSA

Nasal Spray for OSA

Obstructive Sleep Apnea

Pre-clinicalActive

Key Facts

Indication

Obstructive Sleep Apnea

Phase

Pre-clinical

Status

Active

Company

Mosanna Therapeutics

About Mosanna Therapeutics

Mosanna Therapeutics is a private, preclinical-stage biotech pioneering a first-in-class pharmaceutical treatment for obstructive sleep apnea (OSA). Its lead program is a nasal spray designed to reactivate the upper airway muscles during sleep, offering a potential alternative to CPAP machines and other mechanical interventions. Backed by a veteran leadership team with extensive drug development and regulatory experience, the company is positioned to address a massive, underserved market with a therapy focused on biological restoration rather than physical force.

View full company profile

Therapeutic Areas

Sleep Disorders Respiratory

Other Obstructive Sleep Apnea Drugs

Drug	Company	Phase	Status
SANSA® Home Sleep Apnea Test (HSAT)	Huxley Medical	Approved	Active
Wearable Neuromodulation Therapy	XII Medical	Pre-clinical	Active
Transcend Micro 510 Auto CPAP	Somnetics	Approved	Active
iNAP One Sleep Therapy System	Somnics Health	Commercial	Active
iNAP Adjustable	Somnics Health	Commercial	Active
WatchPAT® Home Sleep Apnea Test (HSAT)	Itamar Medical	Commercial	Active
WatchPAT ONE	Itamar Medical	Commercial	Active
Tirzepatide	Eli Lilly	Phase 3	Completed (SURMOUNT-OSA)
WiZARD CPAP Mask	Wellell	Commercial	Active
iCH Auto CPAP System	Wellell	Commercial	Active